表紙
市場調查報告書
商品編碼
1084470

代謝性醫藥品的全球市場:市場規模,佔有率,趨勢,預測(2022年∼2028年)

Metabolism Drugs Market - Size, Share, Trends, and Forecast, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球代謝性醫藥品的市場規模,由於龐貝氏症的盛行率增加,對醫藥品研究開發的政府機關的配合措施,各種治療方法的開發平台的充實,代謝性疾病的高盛行率等所促進。

本報告提供全球代謝性醫藥品市場調查,市場概要,市場規模和預測,趨勢,成長要素,阻礙因素,各治療類型、用途、流通管道、地區的分析,及競爭情形等資訊。

目錄

第1章 調查目的、前提條件

  • 調查目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各治療類型
    • 市場明細:各用途
    • 市場明細:各流通管道
    • 市場明細:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • PEST分析
  • 波特分析
  • 法規情境

第4章 全球代謝性醫藥品市場:各治療類型(2017年∼2028年)

  • 簡介
  • 酵素補充療法
  • 基材減少療法
  • 小分子藥
  • 其他

第5章 全球代謝性醫藥品市場:各用途(2017年∼2028年)

  • 簡介
  • 糖原代謝疾病
  • 脂質代謝疾病
  • 氨基酸代謝疾病
  • 其他

第6章 全球代謝性醫藥品市場:各流通管道(2017年∼2028年)

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第7章 全球代謝性醫藥品市場:各地區(2017年∼2028年)

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第8章 競爭情形

  • 企業簡介
    • Merck &Co., Inc.
    • Application Portfolio
    • Novartis AG
    • Application Portfolio
    • Amicus Therapeutics
    • Application Portfolio
    • AstraZeneca Plc
    • Application Portfolio
    • Boehringer Ingelheim
    • Application Portfolio
    • Shire Plc
    • Application Portfolio
    • Sanofi Genzyme
    • Application Portfolio
    • BioMarin Pharmaceutical, Inc.
    • Application Portfolio
    • Horizon Pharma Plc
    • Application Portfolio
    • GlaxoSmithKline Plc
    • Application Portfolio

第9章 Section

目錄
Product Code: CMI1955

Increasing prevalence of pompe disease is expected to create lucrative opportunities for pharmaceutical manufacturers to develop and commercialize novel treatments for the disease. For instance, according to United Pompe Foundation (UPF), 2021, the estimated incidence of Pompe disease in Holland is 1 in 40,000, in Southern China and Taiwan: 1 in 50,000 births, African-Americans: 1 in 14,000 births and in Caucasian is 1 in 100,000 population. Initiatives from government organizations for drug research and development is supporting growth of the metabolism drugs market.

For instance, in 2016, the scientist from National Institutes of Health researchers collaborated with National Institute of Neurological Disorders and Stroke (NINDS) and the National Center for Advancing Translational Sciences (NCATS) and researchers identified a new molecule that shows promising approach for treatment of the rare gaucher disease. Moreover, in 2014, European Gaucher Alliance launched Gaucher Awareness Day to spread awareness about this rare disease among the population in Europe.

Market Dynamics

Robust pipeline with various therapies such as enzyme replacement therapy, gene therapy, and small molecule drugs is expected to boost the metabolism drugs market over the forecast period. Increased understanding of diseases and rising number of diagnosed patients are expected to increase the number of patients undergoing treatment.

High prevalence of metabolic diseases is expected to support the growth of the metabolism drugs market. For instance, according to the National Institute of Health (NIH) 2018 report, frequency of hunter syndrome is 1 in 100,000 to 1 in 160,000 in males. Enzyme replacement therapy is expected to show significant growth in the metabolism drugs market over the forecast period.

Key features of the study:

This report provides in-depth analysis of metabolism drugs market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new application launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global metabolism drugs market based on the following parameters – company overview, financial performance, application portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Merck & Co., Inc., Novartis AG, Amicus Therapeutics, AstraZeneca Plc, Boehringer Ingelheim, Shire Plc, Sanofi Genzyme, BioMarin Pharmaceutical, Inc., Horizon Pharma Plc, and GlaxoSmithKline Plc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future application launches, technology up-gradation, market expansion, and marketing tactics

The global metabolism drugs market report caters to various stakeholders in this industry including investors, suppliers, application manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the metabolism drugs market

Detailed Segmentation:

Global Metabolism Drugs Market, By Therapy Type:

Enzyme Replacement Therapy

Substrate Reduction Therapy

Small Molecule Drugs

Others

Global Metabolism Drugs Market, By Application:

Glycogen Metabolism Disease

Lipid Metabolism Disease

Amino Acid Metabolism Disease

Others

Global Metabolism Drugs Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Metabolism Drugs Market, By Geography:

North America

By Therapy Type:

Enzyme Replacement Therapy

Substrate Reduction Therapy

Small Molecule Drugs

Others

By Application:

Glycogen Metabolism Disease

Lipid Metabolism Disease

Amino Acid Metabolism Disease

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

U.S.

Canada

Europe

By Therapy Type:

Enzyme Replacement Therapy

Substrate Reduction Therapy

Small Molecule Drugs

Others

By Application:

Glycogen Metabolism Disease

Lipid Metabolism Disease

Amino Acid Metabolism Disease

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Therapy Type:

Enzyme Replacement Therapy

Substrate Reduction Therapy

Small Molecule Drugs

Others

By Application:

Glycogen Metabolism Disease

Lipid Metabolism Disease

Amino Acid Metabolism Disease

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Therapy Type:

Enzyme Replacement Therapy

Substrate Reduction Therapy

Small Molecule Drugs

Others

By Application:

Glycogen Metabolism Disease

Lipid Metabolism Disease

Amino Acid Metabolism Disease

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

Brazil

Mexico

Rest of Latin America

Middle East

By Therapy Type:

Enzyme Replacement Therapy

Substrate Reduction Therapy

Small Molecule Drugs

Others

By Application:

Glycogen Metabolism Disease

Lipid Metabolism Disease

Amino Acid Metabolism Disease

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

GCC

Israel

Rest of Middle East

Africa

By Therapy Type:

Enzyme Replacement Therapy

Substrate Reduction Therapy

Small Molecule Drugs

Others

By Application:

Glycogen Metabolism Disease

Lipid Metabolism Disease

Amino Acid Metabolism Disease

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

Central Africa

South Africa

North Africa

Company Profiles

Merck & Co., Inc.*

Company Overview

Application Portfolio

Financial Performance

Key Strategies

Recent Developments

Novartis AG

Amicus Therapeutics

AstraZeneca Plc

Boehringer Ingelheim

Shire Plc

Sanofi Genzyme

BioMarin Pharmaceutical, Inc.

Horizon Pharma Plc

GlaxoSmithKline Plc

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Therapy Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • PEST Analysis
  • PORTER's Analysis
  • Regulatory Scenario

4. Global Metabolism Drugs Market, By Therapy Type, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Enzyme Replacement Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Substrate Reduction Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Small Molecule Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Metabolism Drugs Market, By Application, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Glycogen Metabolism Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Lipid Metabolism Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Amino Acid Metabolism Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Metabolism Drugs Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Metabolism Drugs Market, By Regions, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
    • Merck & Co., Inc.
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Novartis AG
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Amicus Therapeutics
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AstraZeneca Plc
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Boehringer Ingelheim
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Shire Plc
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sanofi Genzyme
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BioMarin Pharmaceutical, Inc.
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Horizon Pharma Plc
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • GlaxoSmithKline Plc
    • Company Overview
    • Application Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact